Brief: Aeterna Zentaris Announces Evaluation, Potential Development Of Oral Prophylactic Bacterial Vaccine Against COVID-19

COSCIENS Biopharma

02/02/2021 12:34

Feb 2 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS ANNOUNCES EVALUATION AND POTENTIAL
DEVELOPMENT
OF AN ORAL PROPHYLACTIC BACTERIAL VACCINE AGAINST COVID-19
THROUGH EXCLUSIVE OPTION AGREEMENT WITH
JULIUS-MAXIMILIANS-UNIVERSITY WUERZBURG
    * AETERNA ZENTARIS INC - EVALUATE UNIVERSITY'S CORONAVIRUS
VACCINE
PLATFORM TECHNOLOGY INCLUDING COVID-19 UNDER AN EXCLUSIVE OPTION
AGREEMENT
    * AETERNA ZENTARIS - HAS RIGHT TO NEGOTIATE EXCLUSIVE
WORLDWIDE
LICENSE TO DEVELOP TECHNOLOGY FOR PREVENTION OF CORONAVIRUS
DISEASES, INCLUDING COVID-19

Source text for Eikon:  ID:nGNX7tyf4H 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))